M42 combines clinical excellence with AI, advanced technology and genomics to transform healthcare for patients, populations and health systems. Through our global portfolio, we improve outcomes, expand access and deliver impact at scale.
M42 is a global health leader advancing precision, prevention and prediction in health. Headquartered in Abu Dhabi, it operates across key international markets, scaling innovation, enabling collaboration and delivering measurable health impact. Today, its network spans more than 480 facilities across 27 countries.
A market-leading regional hub anchored in Abu Dhabi, UAE, with presence across Bahrain and the Kingdom of Saudi Arabia, delivering advanced, integrated healthcare and driving innovation across the region.
A strong presence across Europe, spanning France, Romania, Spain, Portugal, and other key markets, enabling specialized care, research collaboration, and cross-border innovation.
An expanding footprint across Brazil, Chile, and Uruguay, focused on increasing access to high-quality renal care, reducing health inequities and strengthening regional capabilities.
A strategic presence across China, Kazakhstan, Malaysia and Singapore, where M42 is expanding data-driven renal care services while building partnerships that support future growth, diversification and innovation.
M42 is expanding in Morocco through strategic partnerships and data-driven renal care, strengthening access to high-quality kidney care while helping set new benchmarks for clinical excellence and patient outcomes in the region.
